About Casper Breum
Casper Breum is a director at Artax Biopharma.
Casper Breum reports to the SEC as a director of 1 public company: Spero Therapeutics (SPRO).
Casper Breum first appears on SEC filings in 2017.
Experience
This experience comes from Casper Breum's profile and from SEC filings. For roles taken from filings, the years are when the filings name Casper Breum in the role, so the role may have started earlier or lasted longer.
CL
Cytospire Therapeutics Ltd Current
Board Director
2026 – Present
TT
Teitur Trophics Current
Board Member
2023 – Present
Artax Biopharma, Inc. Current
Director
2022 – Present · Cambridge, MA
Develops oral drug candidates for people with autoimmune diseases.
SB
Sound Bioventures Current
Managing Partner
2021 – Present
VA
VarmX Current
Board Member
2020 – Present
AB
Aura Biosciences
Board Member
2017 – 2021
SL
Sanifit Laboratoris
Board Director
2015 – 2021
AB
Atox Bio
Board Director
2014 – 2021
DL
DySIS Medical Ltd.
Board Director
2013 – 2021
LV
Lundbeckfonden Ventures
Senior Advisor (2009 – 2021)
Board Director (2006 – 2008)
2006 – 2021
SI
Spero Therapeutics, Inc.
Director
2015 – 2018 · Public company (SPRO)
BS
Biom'Up SPAS
Board Director
2015 – 2017
AS
Asante Solutions
Board Director
2014 – 2015
NE
Nexstim
Board Director
2011 – 2015
IS
ilochip A/S
CEO
2008 – 2009
HS
H. Lundbeck A/S
Business Development Manager
2001 – 2008
NS
Niels Clauson-Kaas A/S
Project Manger
1996 – 2001
NS
Novo Nordisk A/S
Quality Assuarance Manager
1993 – 1996
Key Colleagues at Startups
The people Casper Breum works with at each company, as listed on that company's latest Form D.
Artax Biopharma, Inc. · Form D/A, May 5, 2026
Joe Suarez
Chief Financial Officer
Andre Hoekema
Board Chair
Maria Nichol
Chief Business Officer
AW
Alan Walts
Director
DD
Damia Tormo, Ph.D.
Director
GS
Gino Santini
Director
RP
Raj Parekh
Director
Robert Armstrong, Ph.D.
Chief Executive Officer and director